Skip to main content
Top
Published in: Clinical Journal of Gastroenterology 2/2024

09-01-2024 | Constipation | Case Report

Chronic intestinal pseudo-obstruction due to adult-onset acquired isolated hypoganglionosis with muscular atrophy in the small intestine: a case report and review of literature

Authors: Sayoko Tayama, Yoki Furuta, Miyuki Morito, Hideaki Naoe, Daiki Yoshii, Yasuyuki Uchida, Koichiro Yoshimaru, Yuji Miyamoto, Tomoaki Taguchi, Yasuhito Tanaka

Published in: Clinical Journal of Gastroenterology | Issue 2/2024

Login to get access

Abstract

Background

Chronic intestinal pseudo-obstruction (CIPO) is a rare intestinal disorder characterized by impaired propulsion of the digestive tract and associated with symptoms of intestinal obstruction, despite the absence of obstructive lesions. CIPO includes several diseases. However, definitive diagnosis of its etiology is difficult only with symptoms or imaging findings.

Case presentation

A 56-year-old man was referred to our hospital due to a 3-year history of continuous abdominal distention. Imaging, including computed tomography of the abdomen, and endoscopy revealed marked dilatation of the entire small intestine without any obstruction point. Therefore, he was diagnosed with CIPO. Since medical therapy didn’t improve his symptoms, enterostomy and percutaneous endoscopic gastro-jejunostomy were performed. These procedures improved abdominal symptoms. However, he required home central venous nutrition due to dehydration. The pathological findings of full-thickness biopsies of the small intestine taken during surgery revealed decreased number and degeneration of ganglion cells in the normal plexus. These findings led to a final diagnosis of CIPO due to acquired isolated hypoganglionosis (AIHG).

Conclusions

Here, we report the case of a patient with CIPO secondary to adult-onset AIHG of the small intestine. Since AIHG cannot be solely diagnosed using clinical findings, biopsy is important for its diagnosis.
Appendix
Available only for authorised users
Literature
1.
go back to reference De Giorgio R, Sarnelli G, Corinaldesi R, et al. Advances in our understanding of the pathology of chronic intestinal pseudo-obstruction. Gut. 2004;53:1549–52.CrossRefPubMedPubMedCentral De Giorgio R, Sarnelli G, Corinaldesi R, et al. Advances in our understanding of the pathology of chronic intestinal pseudo-obstruction. Gut. 2004;53:1549–52.CrossRefPubMedPubMedCentral
2.
go back to reference Muto M, Matsufuji H, Taguchi T, et al. Japanese clinical practice guidelines for allied disorders of Hirschsprung’s disease, 2017. Pediatr Int. 2018;60:400–10.CrossRefPubMed Muto M, Matsufuji H, Taguchi T, et al. Japanese clinical practice guidelines for allied disorders of Hirschsprung’s disease, 2017. Pediatr Int. 2018;60:400–10.CrossRefPubMed
3.
go back to reference Taguchi T, Masumoto K, Ieiri S, et al. New classification of hypoganglionosis: congenital and acquired hypoganglionosis. J Pediatr Surg. 2006;41:2046–51.CrossRefPubMed Taguchi T, Masumoto K, Ieiri S, et al. New classification of hypoganglionosis: congenital and acquired hypoganglionosis. J Pediatr Surg. 2006;41:2046–51.CrossRefPubMed
4.
go back to reference Fang XC, Ke MY, Zhang XL. Diagnosis and treatment for the chronic intestinal pseudo obstruction: a report of 7 cases. World J Gastroenterol. 1996;2:184–184. Fang XC, Ke MY, Zhang XL. Diagnosis and treatment for the chronic intestinal pseudo obstruction: a report of 7 cases. World J Gastroenterol. 1996;2:184–184.
6.
go back to reference Tanaka K, Ohkubo H, Yamamoto A, et al. Natural history of chronic intestinal pseudo-obstruction and need for palliative care. J Neurogastroenterol Motil. 2023;29:378–87.CrossRefPubMedPubMedCentral Tanaka K, Ohkubo H, Yamamoto A, et al. Natural history of chronic intestinal pseudo-obstruction and need for palliative care. J Neurogastroenterol Motil. 2023;29:378–87.CrossRefPubMedPubMedCentral
7.
go back to reference Dukowicz AC, Lacy BE, Levine GM. Small intestinal bacterial overgrowth: a comprehensive review. Gastroenterol Hepatol (NY). 2007;3:112–22. Dukowicz AC, Lacy BE, Levine GM. Small intestinal bacterial overgrowth: a comprehensive review. Gastroenterol Hepatol (NY). 2007;3:112–22.
8.
go back to reference Taguchi T, Ieiri S, Miyoshi K, et al. The incidence and outcome of allied disorders of Hirschsprung’s disease in Japan: results from a nationwide survey. Asian J Surg. 2017;40:29–34.CrossRefPubMed Taguchi T, Ieiri S, Miyoshi K, et al. The incidence and outcome of allied disorders of Hirschsprung’s disease in Japan: results from a nationwide survey. Asian J Surg. 2017;40:29–34.CrossRefPubMed
9.
go back to reference Pescatori M, Mattana C, Castiglioni GC. Adult megacolon due to total hypoganglionosis. Brit J Surg. 1986;73:765–765.CrossRefPubMed Pescatori M, Mattana C, Castiglioni GC. Adult megacolon due to total hypoganglionosis. Brit J Surg. 1986;73:765–765.CrossRefPubMed
10.
go back to reference Matsui T, Iwashita A, Iida M, et al. Acquired pseudoobstruction of the colon due to segmental hypoganglionosis. Gastrointest Radiol. 1987;12:262–4.CrossRefPubMed Matsui T, Iwashita A, Iida M, et al. Acquired pseudoobstruction of the colon due to segmental hypoganglionosis. Gastrointest Radiol. 1987;12:262–4.CrossRefPubMed
11.
go back to reference Niwamoto H, Okamoto E, Toyosaka A, et al. Sporadic visceral neuropathy. Surg Today. 1995;25:763–70.CrossRefPubMed Niwamoto H, Okamoto E, Toyosaka A, et al. Sporadic visceral neuropathy. Surg Today. 1995;25:763–70.CrossRefPubMed
12.
go back to reference Smith VV, Gregson N, Foggensteiner L, et al. Acquired intestinal aganglionosis and circulating autoantibodies without neoplasia or other neural involvement. Gastroenterology. 1997;112:1366–71.CrossRefPubMed Smith VV, Gregson N, Foggensteiner L, et al. Acquired intestinal aganglionosis and circulating autoantibodies without neoplasia or other neural involvement. Gastroenterology. 1997;112:1366–71.CrossRefPubMed
13.
go back to reference Faussone-Pellegrini MS, Fociani P, Buffa R, et al. Loss of interstitial cells and a fibromuscular layer on the luminal side of the colonic circular muscle presenting as megacolon in an adult patient. Gut. 1999;45:775–9.CrossRefPubMed Faussone-Pellegrini MS, Fociani P, Buffa R, et al. Loss of interstitial cells and a fibromuscular layer on the luminal side of the colonic circular muscle presenting as megacolon in an adult patient. Gut. 1999;45:775–9.CrossRefPubMed
14.
go back to reference Wedel T, Spiegler J, Soellner S, et al. Enteric nerves and interstitial cells of Cajal are altered in patients with slow-transit constipation and megacolon. Gastroenterology. 2002;123:1459–67.CrossRefPubMed Wedel T, Spiegler J, Soellner S, et al. Enteric nerves and interstitial cells of Cajal are altered in patients with slow-transit constipation and megacolon. Gastroenterology. 2002;123:1459–67.CrossRefPubMed
15.
go back to reference Ito T, Kimura T, Yagami T, et al. Megacolon in an adult case of hypoganglionosis, a pseudo-Hirschsprung’s disease: an autopsy study. Intern Med. 2008;47:421–5.CrossRefPubMed Ito T, Kimura T, Yagami T, et al. Megacolon in an adult case of hypoganglionosis, a pseudo-Hirschsprung’s disease: an autopsy study. Intern Med. 2008;47:421–5.CrossRefPubMed
16.
17.
go back to reference Do MY, Myung SJ, Park HJ, et al. Novel classification and pathogenetic analysis of hypoganglionosis and adult-onset Hirschsprung’s disease. Dig Dis Sci. 2011;56:1818–27.CrossRefPubMed Do MY, Myung SJ, Park HJ, et al. Novel classification and pathogenetic analysis of hypoganglionosis and adult-onset Hirschsprung’s disease. Dig Dis Sci. 2011;56:1818–27.CrossRefPubMed
19.
go back to reference Han EC, Oh HK, Ha HK, et al. Favorable surgical treatment outcomes for chronic constipation with features of colonic pseudo-obstruction. World J Gastroenterol. 2012;18:4441–6.CrossRefPubMedPubMedCentral Han EC, Oh HK, Ha HK, et al. Favorable surgical treatment outcomes for chronic constipation with features of colonic pseudo-obstruction. World J Gastroenterol. 2012;18:4441–6.CrossRefPubMedPubMedCentral
20.
go back to reference Cho KM, Lim SK, Park SY, et al. A case of colonic hypoganglionosis complicated with colonic ulcers. Soonchunhyang Med Sci. 2015;21:36–9.CrossRef Cho KM, Lim SK, Park SY, et al. A case of colonic hypoganglionosis complicated with colonic ulcers. Soonchunhyang Med Sci. 2015;21:36–9.CrossRef
21.
go back to reference Gabbani T, Marsico M, Marocchi M, et al. Isolated hypoganglionosis in young man with autism. Dig Liver Dis. 2017;49:104.CrossRefPubMed Gabbani T, Marsico M, Marocchi M, et al. Isolated hypoganglionosis in young man with autism. Dig Liver Dis. 2017;49:104.CrossRefPubMed
23.
go back to reference Kwok AM, Still AB, Hart K. Acquired segmental colonic hypoganglionosis in an adult Caucasian male: a case report. World J Gastrointest Surg. 2019;11:101–11.CrossRefPubMedPubMedCentral Kwok AM, Still AB, Hart K. Acquired segmental colonic hypoganglionosis in an adult Caucasian male: a case report. World J Gastrointest Surg. 2019;11:101–11.CrossRefPubMedPubMedCentral
24.
go back to reference Lee A, Suhardja TS, Simpson I, et al. Rare case of adult intestinal hypoganglionosis and review of the literature. Clin J Gastroenterol. 2021;14:599–607.CrossRefPubMed Lee A, Suhardja TS, Simpson I, et al. Rare case of adult intestinal hypoganglionosis and review of the literature. Clin J Gastroenterol. 2021;14:599–607.CrossRefPubMed
25.
go back to reference Tominaga T, Nagayama S, Takamatsu M, et al. A case of severe megacolon due to acquired isolated hypoganglionosis after low anterior resection for lower rectal cancer. Clin J Gastroenterol. 2020;13:328–33.CrossRefPubMed Tominaga T, Nagayama S, Takamatsu M, et al. A case of severe megacolon due to acquired isolated hypoganglionosis after low anterior resection for lower rectal cancer. Clin J Gastroenterol. 2020;13:328–33.CrossRefPubMed
29.
go back to reference Obata S, Yoshimaru K, Kirino K, et al. Acquired isolated hypoganglionosis as a distinct entity: results from a nationwide survey. Pediatr Surg Int. 2019;35:215–20.CrossRefPubMed Obata S, Yoshimaru K, Kirino K, et al. Acquired isolated hypoganglionosis as a distinct entity: results from a nationwide survey. Pediatr Surg Int. 2019;35:215–20.CrossRefPubMed
30.
go back to reference Yoshimaru K, Taguchi T, Obata S, et al. Immunostaining for Hu C/D and CD56 is useful for a definitive histopathological diagnosis of congenital and acquired isolated hypoganglionosis. Virchows Arch. 2017;470:679–85.CrossRefPubMed Yoshimaru K, Taguchi T, Obata S, et al. Immunostaining for Hu C/D and CD56 is useful for a definitive histopathological diagnosis of congenital and acquired isolated hypoganglionosis. Virchows Arch. 2017;470:679–85.CrossRefPubMed
31.
go back to reference Poisson J, Devroede G. Severe chronic constipation as a surgical problem. Surg Clin North Am. 1983;63:193–217.CrossRefPubMed Poisson J, Devroede G. Severe chronic constipation as a surgical problem. Surg Clin North Am. 1983;63:193–217.CrossRefPubMed
Metadata
Title
Chronic intestinal pseudo-obstruction due to adult-onset acquired isolated hypoganglionosis with muscular atrophy in the small intestine: a case report and review of literature
Authors
Sayoko Tayama
Yoki Furuta
Miyuki Morito
Hideaki Naoe
Daiki Yoshii
Yasuyuki Uchida
Koichiro Yoshimaru
Yuji Miyamoto
Tomoaki Taguchi
Yasuhito Tanaka
Publication date
09-01-2024
Publisher
Springer Nature Singapore
Published in
Clinical Journal of Gastroenterology / Issue 2/2024
Print ISSN: 1865-7257
Electronic ISSN: 1865-7265
DOI
https://doi.org/10.1007/s12328-023-01902-x

Other articles of this Issue 2/2024

Clinical Journal of Gastroenterology 2/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.